货号：GS40347
Itepekimab is a fully human monoclonal antibody developed by Sanofi. It selectively targets and inhibits interleukin-33 (IL-33), a key alarmin cytokine involved in initiating and amplifying type 2 inflammatory responses in epithelial barriers (like the airways and skin). By blocking IL-33 signaling through its receptor ST2, itepekimab aims to treat inflammatory diseases driven by this pathway, with its most advanced clinical development in moderate-to-severe asthma and chronic obstructive pulmonary disease (COPD).
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook，有助于交易顺利完成！
冉凯凯